Respiratory Distress Syndrome Management in Newborns

Initial Respiratory Support

• The American Academy of Pediatrics recommends continuous positive airway pressure (CPAP) started at or soon after birth with subsequent selective surfactant administration as needed, particularly in preterm infants 1, 2
• For spontaneously breathing preterm infants with respiratory distress, CPAP should be initiated immediately after birth as the first-line respiratory support 3, 4
• CPAP helps prevent atelectasis in newborns and is especially helpful for preterm infants with breathing difficulty after birth or after resuscitation 3
• CPAP may reduce the risk of death or bronchopulmonary dysplasia in very preterm infants when compared with endotracheal intubation and positive pressure ventilation (PPV) 3

Surfactant Administration

• Preterm infants born at <30 weeks' gestation who need mechanical ventilation because of severe RDS should be given surfactant after initial stabilization 5, 6
• Early rescue surfactant treatment (<2 hours of age) in infants with established RDS decreases the risk of mortality, air leak, and chronic lung disease 6

Treatment Algorithm for RDS in Newborns

Step 1: Initial Assessment and Stabilization

• Assess respiratory effort, heart rate, and oxygen saturation immediately after birth 7

Step 2: Choose Initial Respiratory Support

• For spontaneously breathing preterm infants with respiratory distress, start with CPAP at 5-6 cm H₂O 3, 1
• Avoid excessive chest wall movement during ventilation 7

Step 3: Oxygen Management

• Start with the lowest effective FiO2 to maintain target oxygen saturation 3
• Titrate oxygen based on continuous pulse oximetry monitoring 7

Step 4: Surfactant Administration Decision

• Consider selective surfactant administration for preterm infants on CPAP who show worsening respiratory distress 5, 6
• The INSURE technique (Intubation, Surfactant administration, and Extubation to CPAP) may be used for surfactant delivery 1, 2

Common Pitfalls to Avoid

• Delaying initiation of CPAP in spontaneously breathing preterm infants 3, 1
• Using unnecessarily high ventilation pressures that can cause lung injury 7
• Routine intubation and prophylactic surfactant without a trial of CPAP in preterm infants who are breathing spontaneously 1, 2

Respiratory Support in Neonates with RDS

Evidence-Based Recommendations

• The American Heart Association recommends using the minimal inflation pressure necessary to achieve heart rate improvement or chest expansion, typically 20-25 cm H₂O for preterm infants and 30 cm H₂O for term infants, with CPAP at 5-6 cm H₂O as first-line therapy 8
• There is no evidence supporting inflation pressures higher than those necessary to achieve improvement in heart rate or chest expansion, as excessive pressure delivery can cause lung injury 8
• Initial inflation pressure of 20-25 cm H₂O is adequate for most preterm infants, and CPAP should be initiated at 5-6 cm H₂O immediately after birth for spontaneously breathing preterm infants with respiratory distress 8
• For term infants, initial inflation pressure of 30 cm H₂O is usually effective, though occasionally 30-40 cm H₂O may be necessary, and the minimal inflation required to achieve an increase in heart rate should be used 8
• PEEP is beneficial during initial stabilization of apneic preterm infants requiring positive-pressure ventilation and should be used if suitable equipment is available, but high levels of PEEP (8-12 cm H₂O) may reduce pulmonary blood flow and increase the risk of pneumothorax 8
• Early CPAP reduces the need for mechanical ventilation and surfactant use in infants 25-28 weeks' gestation, with a relative risk of 0.53 (95% CI 0.34-0.83) 8
• CPAP use is associated with increased pneumothorax rate (9% versus 3% with intubation), highlighting the need for careful monitoring and pressure management 8

Respiratory Management of Preterm Neonates with CPAP and Selective Surfactant

Initial Non‑invasive Ventilation (CPAP)

• Immediate use of CPAP (5–6 cm H₂O) after birth, with selective surfactant only if CPAP fails, lowers the combined risk of bronchopulmonary dysplasia and death compared with routine intubation and prophylactic surfactant. This recommendation is supported by Level 1 evidence from the American Academy of Pediatrics. 9

Selective Surfactant Administration

• Preterm infants younger than 30 weeks gestation who require mechanical ventilation after initial stabilization should receive surfactant therapy. The American Academy of Pediatrics endorses this selective approach. 9

Avoidance of Prophylactic Surfactant

• Administering prophylactic surfactant to infants already receiving CPAP increases the risk of death or chronic lung disease (relative risk 1.13; 95 % CI 1.02–1.25). Evidence from the American Academy of Pediatrics advises against this practice. 9

Post‑natal Steroid Use

• Post‑natal corticosteroids are not indicated for the initial management of respiratory distress syndrome in preterm neonates; they are reserved for later phases or specific indications. This guidance is based on recommendations from the American Academy of Pediatrics. 9